FWC for the supply of for the supply of mRNA COVID-19 vaccine.
Awarded
The competition has ended and a winner has been selected.
- Qualification deadline
- Jan 22, 2025Expired
- Award
- Pris 30%
Brief
The subject matter of the FWC is the supply of up to 146 000 000 (one hundred and forty-six million) doses of the latest approved mRNA COVID-19 vaccine with EU Marketing authorisation.
Farmasøytisk engroshandel
Result
- Moderna Netherlands B.V.Winner
- 1Number of bids
- Not statedContract value
Custom Assessment Criteria
Get answers to your bid/no-bid criteria
Set them up once and Cobrief answers them in every tender
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
Vennligst se anskaffelsesdokumentene.
Source
No source found in the documents. Check the weight against the tender documents.
Description
Vennligst se anskaffelsesdokumentene.
Source
No source found in the documents. Check the weight against the tender documents.
Previous winners
Who are you up against?
The suppliers who have won similar contracts at European Commission, DG HERA - European Health Emergency Preparedness and Response Authority
From the notice
The subject matter of the FWC is the supply of up to 146 000 000 (one hundred and forty-six million) doses of the latest approved mRNA COVID-19 vaccine with EU Marketing authorisation.
Contact
HERA-JOINT-PROCUREMENT-SECRETARIAT@ec.europa.eu- Result · Framework agreement · PrequalificationType
- 33000000Main codeMedical equipments, pharmaceuticals and personal care products
- 33100000Medical equipments33600000Pharmaceutical products